SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001395064-22-000069
Filing Date
2022-05-09
Accepted
2022-05-09 06:10:39
Documents
1
Period of Report
2022-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 3/A wf-form3a_165209102472594.html 3/A  
1 FORM 3/A wf-form3a_165209102472594.xml 3/A 6473
  Complete submission text file 0001395064-22-000069.txt   8577
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41365 | Film No.: 22903128
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Issuer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 781.266.5387
Takeda Vaccines, Inc. (Reporting) CIK: 0001905616 (see all company filings)

State of Incorp.: DE
Type: 3/A | Act: 34 | File No.: 001-41365 | Film No.: 22903127